News Events
March 26, 2010
Escape develops a novel biomaterial for tissue engineering applications.
Escape Therapeutics announces the online publication of its research on MorphoGel™, a novel hybrid hydrogel biomaterial for use in tissue engineering applications. The article is titled "Support of human adipose-derived mesenchymal stem cell multipotency by a poloxamer-octapeptide hybrid hydrogel." The study was led by Dr. Hantash, Escape's CEO, and his team of scientists. The development of new biological materials, particularly those capable of serving as permissive substrates for cell growth, differentiation, and biological function, is a key area for advancing medical technology. In this study, MorphoGel™ significantly increased human adipose-derived mesenchymal stem cell proliferation rates while supporting multipotency both in vitro and in vivo. Escape's study shows that MorphoGel™ maintains improved mechanical properties and bioactivity relative to its individual constituents, supporting its potential use as a stem cell scaffold in soft tissue engineering applications.